FEBS Letters · 1999 · 269 citations · 41 references
The deposition of beta-amyloid peptide (A beta), the hyperphosphorylation of tau protein and the death of neurons in certain brain regions are characteristic features of Alzheimer's disease. It has been proposed that the accumulation of aggregates of A beta is the trigger of neurodegeneration in this disease. In support of this view, several studies have demonstrated that the treatment of cultured neurons with A beta leads to the hyperphosphorylation of tau protein and neuronal cell death. Here we report that lithium prevents the enhanced phosphorylation of tau protein at the sites recognized by antibodies Tau-1 and PHF-1 which occurs when cultured rat cortical neurons are incubated with A beta. Interestingly, lithium also significantly protects cultured neurons from A beta-induced cell death. These results raise the possibility of using chronic lithium treatment for the therapy of Alzheimer's disease.
41
Inge Grundke‐Iqbal, Khurshid Iqbal, Y C Tung et al. · Proceedings of the National Academy of Sciences · 1986 · 3.6K citations · Full text
Molecular Biology, Cytoskeleton, Microtubule-associated Protein Tau +19
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Christine Stürchler-Pierrat, Dorothée Abramowski, Mairead Duke et al. · Proceedings of the National Academy of Sciences · 1997 · 1.5K citations · Full text
Neurodegenerative Diseases, Alzheimer's Disease, Transgenic Mouse Models +15
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Teresa Gómez‐Isla, Richard Hollister, Howard West et al. · Annals of Neurology · 1997 · 1.5K citations